Literature DB >> 1571419

Aspergillus species colonization and invasive disease in patients with AIDS.

K J Pursell1, E E Telzak, D Armstrong.   

Abstract

Invasive aspergillosis is an uncommon infectious complication in patients with AIDS. Of the 972 patients with AIDS who were observed at our institution over a 10-year period, Aspergillus species were isolated from the respiratory sites of 45 patients before death. Invasive aspergillosis was documented at autopsy in four of these patients and was strongly suspected in an additional patient on whom an autopsy was not performed. A fifth case was documented at autopsy (no antemortem respiratory sample was obtained from this patient). Traditional risk factors for the development of invasive disease (neutropenia, hematologic malignancy, and/or corticosteroid use) were present in all of our patients with invasive aspergillosis. A review of the literature revealed reports of an additional 13 cases of invasive aspergillosis in patients with AIDS. Therapy with amphotericin B should be considered for neutropenic patients with AIDS who have pneumonia of uncertain etiology and from whom Aspergillus species have been isolated from a respiratory specimen.

Entities:  

Mesh:

Year:  1992        PMID: 1571419     DOI: 10.1093/clinids/14.1.141

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Epidemiology of invasive fungal infections in patients with acquired immunodeficiency syndrome at a reference hospital for infectious diseases in Brazil.

Authors:  Renata Buccheri de Oliveira; Jane Harumi Atobe; Simone Aparecida Souza; Daniel Wagner de Castro Lima Santos
Journal:  Mycopathologia       Date:  2014-06-21       Impact factor: 2.574

3.  Detection of Aspergillus DNA in bronchoalveolar lavage fluid of AIDS patients by the polymerase chain reaction.

Authors:  E Bart-Delabesse; A Marmorat-Khuong; J M Costa; M L Dubreuil-Lemaire; S Bretagne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

4.  Fungicidal activity of cecropin A.

Authors:  A J DeLucca; J M Bland; T J Jacks; C Grimm; T E Cleveland; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp.

Authors:  A J De Lucca; T J Walsh; D J Daigle
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

6.  Proton-pumping-ATPase-targeted antifungal activity of a novel conjugated styryl ketone.

Authors:  E K Manavathu; J R Dimmock; S C Vashishtha; P H Chandrasekar
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

7.  Management of pulmonary aspergillosis in AIDS: an emerging clinical problem.

Authors:  J J Keating; T Rogers; M Petrou; J D Cartledge; D Woodrow; M Nelson; D A Hawkins; B G Gazzard
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

8.  Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation.

Authors:  S Kusne; J Torre-Cisneros; R Mañez; W Irish; M Martin; J Fung; R L Simmons; T E Starzl
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

9.  Catheter-related cutaneous aspergillosis complicated by fungemia and fatal pulmonary infection in an HIV-positive patient with acute lymphocytic leukemia.

Authors:  C Girmenia; R Gastaldi; P Martino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

Review 10.  Endemic mycosis complicating human immunodeficiency virus infection.

Authors:  G A Sarosi; S F DAvies
Journal:  West J Med       Date:  1996-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.